Understanding Cernos
Cernos 40 mg Sun Pharmaceuticals Industries is a pharmaceutical-grade testosterone undecanoate formulation manufactured by Sun Pharmaceutical Industries Limited. This oral testosterone ester compound represents a long-acting androgenic steroid designed for comprehensive endocrine system research and hormonal pathway investigations. The undecanoate ester provides extended release characteristics, making it valuable for studying sustained androgen receptor activation patterns in controlled laboratory environments. Research scientists investigating hormonal replacement therapy models, androgen receptor binding studies, and testosterone metabolism pathways utilise this compound for its consistent pharmaceutical manufacturing standards. The 40 mg capsule formulation offers precise dosing control for experimental protocols requiring standardised testosterone delivery systems. Our research facility at Stroid UK Shop maintains strict quality control standards for all pharmaceutical compounds, ensuring researchers receive authentic products suitable for advanced scientific investigation.
Laboratory Research Applications
Scientific investigations with Cernos examine testosterone undecanoate pharmacokinetics, androgen receptor tissue selectivity, and hormonal replacement therapy efficacy models. Research protocols evaluate the compound’s oral bioavailability characteristics compared to injectable testosterone formulations, providing insights into ester-based delivery mechanisms. Endocrinology laboratories study this formulation’s impact on hypothalamic-pituitary-gonadal axis function, investigating feedback loops and hormonal regulation patterns. Advanced research examines testosterone undecanoate’s tissue-specific distribution, metabolism through hepatic pathways, and conversion to active metabolites including dihydrotestosterone and estradiol. Comparative studies between oral and injectable testosterone delivery systems utilise Cernos to evaluate absorption rates, peak plasma concentrations, and duration of androgenic effects. Our comprehensive testosterone research collection supports diverse experimental protocols requiring standardised androgenic compounds. Researchers investigating male hormone replacement therapy models examine this compound alongside selective androgen receptor modulators and peptide hormones for comprehensive endocrine system analysis.
Technical Specifications
| Active Compound | Testosterone Undecanoate |
|---|---|
| Dosage Form | 40 mg Oral Capsules |
| Manufacturer | Sun Pharmaceutical Industries Limited |
| CAS Number | 5949-44-0 |
| Molecular Formula | C₃₀H₄₈O₃ |
| Molecular Weight | 456.7 g/mol |
| Storage Conditions | Room temperature, dry environment, protected from light |
| Purity Grade | Pharmaceutical standard |
| Research Classification | Androgenic anabolic steroid ester |
Research Compliance Statement
Cernos 40 mg Sun Pharmaceuticals Industries is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This pharmaceutical compound is not intended for human consumption, therapeutic use, or any clinical applications. Research institutions and qualified laboratories should handle this material according to established safety protocols for hormonal research compounds. Proper laboratory equipment, trained personnel, and appropriate disposal methods are essential for safe handling procedures. All research applications must comply with local regulations governing controlled substance research and institutional review board approvals where applicable.
